Results 51 to 60 of about 5,638,603 (255)

Споредба на лапаро- ÑкопÑка херниоплаÑтика Ñо конвенционална техника кај женÑки деца Ñо индиректна ингвинална хернија [PDF]

open access: yes, 2017
The study aims to compare the conventional open technique for treating inguinal hernia versus laparoscopic assisted technique of percutaneous closure of the internal inguinal ring in female children with clinically diagnosed indirect inguinal hernia ...
РиÑтеÑки (Risteski), Тони (Toni) Мирче (Mirce)   +4 more
core   +1 more source

Neurolupus [PDF]

open access: yes, 2015
СиÑтемÑки Ð»ÑƒÐ¿ÑƒÑ ÐµÑ€Ð¸Ñ‚ÐµÐ¼Ð°Ñ‚Ð¾Ð·ÑƒÑ (СЛЕ) не е невообичаена ÑоÑтојба. Повеќето невролози Ñе ÑвеÑни дека Ñ‚aa може да предизвика широк Ñпектар на невроР...
Bundovska, Smiljana, Kuzmanovska, Dafina
core   +2 more sources

Circulating histones as clinical biomarkers in critically ill conditions

open access: yesFEBS Letters, EarlyView.
Circulating histones are emerging as promising biomarkers in critical illness due to their diagnostic, prognostic, and therapeutic potential. Detection methods such as ELISA and mass spectrometry provide reliable approaches for quantifying histone levels in plasma samples.
José Luis García‐Gimenez   +17 more
wiley   +1 more source

Insights into pegRNA design from editing of the cardiomyopathy‐associated phospholamban R14del mutation

open access: yesFEBS Letters, EarlyView.
This study reveals how prime editing guide RNA (pegRNA) secondary structure and reverse transcriptase template length affect prime editing efficiency in correcting the phospholamban R14del cardiomyopathy‐associated mutation. Insights support the design of structurally optimized enhanced pegRNAs for precise gene therapy.
Bing Yao   +7 more
wiley   +1 more source

Contemporary Views of Iron Homeostasis with Main Focus of Hepcidin - New Hormone Regulator of Iron Metabolism [PDF]

open access: yes, 2015
Железото е еÑенцијален елемент за Ñкоро Ñите живи организми. Тој е клучен функционален дел на киÑлородните транÑпортери, депонирачките моР...
Ilkovska, Biljana   +2 more
core   +2 more sources

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink   +6 more
wiley   +1 more source

Е-кадеринот и неговата улога кај пациентки Ñо Ñерозен оваријален карцином во напреднат Ñтадиум [PDF]

open access: yes, 2017
Ovarian cancer is the fifth leading cause of cancer deaths and has the highest mortality rate among gynecologic cancers in women in North America and Europe.The aim of this study wasto analyze the correlation between E-cadherin expression and clinical ...
ÐлулоÑки, Игор
core   +1 more source

Structure of Patients Treated in Intensive Coronary Care Unit on Department for Internal Medicine – PHO General Hospital Kumanovo – in the Period from 2009-2013 Year [PDF]

open access: yes, 2015
ОСÐОВÐ: Главната функција на коронарната единица е доÑтапноÑÑ‚ на телеметрија или континуирано Ñледење на Ñрцевиот ритам и крвниот притиÑок пр
Anchevski, Tomica
core   +2 more sources

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy